Englewood, Colorado, United States The company was established in North America in United States. The main department of described VC is located in the Englewood.
Besides them, we counted 1 critical employee of this fund in our database.
The standard case for the fund is to invest in rounds with 8 partakers. Despite the Mossrock Capital, startups are often financed by Vivo Capital, Sofinnova Investments, F-Prime Capital. The meaningful sponsors for the fund in investment in the same round are Vivo Capital, Sofinnova Investments, Rock Springs Capital. In the next rounds fund is usually obtained by Aisling Capital.
Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Therapeutics, Pharmaceutical. Among the most popular portfolio startups of the fund, we may highlight Aclaris Therapeutics.
The higher amount of exits for fund were in 2015. The fund is constantly included in less than 2 investment rounds annually. The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2015.
Related Funds
| Fund Name | Location |
| 3LB Seed Capital Srl | Italy, Piemonte, Torino |
| Asian E-Commerce Alliance | Germany, Hamburg |
| Chuangfu Investment Management | China, Shanghai |
| Dongfang Hanhua Wenhua | Beijing, China, Shijingshan |
| Essex Innovation | Chelmsford, Essex, United Kingdom |
| Fathom Capital | California, San Francisco, United States |
| Giant Network | China, Shanghai |
| Global Frontier Investments | - |
| Hubei Hongxu Investment | China, Fujian, Hubei |
| Infina Finance | - |
| InterCure | HaMerkaz, Israel, Ra'anana |
| Lita | Oregon, Portland, United States |
| Meyer Bergman | England, London, United Kingdom |
| Newegg | California, City Of Industry, United States |
| Next Step Labs | - |
| Orchard Global Asset Management | Central, Central Region, Singapore |
| Shaoxing king investment development co., Ltd | China, Shaoxing, Zhejiang |
| TRIVE | Central, Central Region, Singapore |
| UNC REX Healthcare | North Carolina, Raleigh, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
SomaLogic | $121M | 25 Nov 2020 | Boulder, Colorado, United States | ||
Aclaris Therapeutics | $40M | 09 Sep 2015 | Pennsylvania, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
SomaLogic | $121M | 25 Nov 2020 | Boulder, Colorado, United States | ||
Aclaris Therapeutics | $40M | 09 Sep 2015 | Pennsylvania, United States |
